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ABSTRACT
Objectives: The objective behind the study is to develop a mucoadhesive rectal hydrogel from carbamazepine (CBZ) – rice bran wax (RBW) 
microspheres for the purpose of controlled release for the treatment of epilepsy.
Methods: The study was conducted to formulate controlled release rectal hydrogel loaded with CBZ – RBW microspheres in two different natural polymers, 
RBW and collagen which are prepared by modified cooling induced solidification method and gel preparation along with their evaluation studies.
Results: A thorough analysis of the optimized gel revealed that all the evaluation parameters evaluated are within the acceptable limits. Further, the 
optimized microsphere formulation (M5) was used to formulate it as rectal hydrogel using polymer collagen and was characterized. The mucoadhesion 
time of 25% w/w collagen hydrogel (H4) was 565 minutes, allowing the loaded microspheres to be attached on rectal mucosa. In vitro drug release 
from the mucoadhesive hydrogel formulations showed controlled drug release pattern with a maximum drug release of 96.45±0.35% for optimized 
H4 formulation after 12 hr, followed zero order release pattern with diffusion mediated Higuchi model. Ex vivo permeation studies using bovine rectal 
mucosa revealed that H4 formulation showed greater permeability compared to control. Histopathological findings revealed that H4 formulation is 
safer for rectal administration without any signs of rectal irritancy. The stability studies of optimized formulation (H4) proved that hydrogel remained 
stable over a wide range of temperature condition.
Conclusion: Hence, the developed rectal hydrogel formulation seems to be a viable alternative to conventional drug delivery system for the effective 
management of epilepsy.
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INTRODUCTION
Epilepsy is a disorder of brain that is characterized by neuronal misfiring 
and send out incorrect signals, ultimately lead to seizures. Seizures can 
vary between brief loss of awareness, to mood swings, to loss of body 
function and motor control [1]. Pathophysiology of epilepsy is very 
complex. Pathophysiological mechanisms of some forms of epilepsy are 
partially understood [2].
Antiepileptic drugs (AEDs) are different group of pharmaceuticals used 
in the treatment of epileptic seizures. The major targets for the marketed 
AEDs are voltage-gated sodium channel and components of GABA system 
(GABAA receptor, GAT-1 GABA transporter). Other considerable targets 
are voltage gated calcium channels, SV2A.For a long time, it was tried to 
develop a single drug for the treatment of all type of epilepsies. Specific 
choices of AED depend on the individual patient’s condition and the 
particular side effects of the AED. None has emerged as being superior to 
either old standard or newer AED drugs [3-6]. The article mainly focused 
on the development and evaluation of rectal collagen hydrogel loaded 
with carbamazepine (CBZ) rice bran wax (RBW) microspheres adequate 
for the purpose of sustaining its release in case of long-term therapy 
which is highly essential in the treatment of epilepsy.
MATERIALS AND METHODS
Materials
CBZ sample was procured from Bajaj Private Ltd., Mumbai. Matruby 
Trades and Solutions Private Limited, Kochi, supplied the RBWs. 
Collagen was obtained from Nitta Gelatin Chemicals, Kochi. All other 
chemicals used were of analytical grade.
Preformulation studies
Preformulation studies are the first step in the rational development of 
dosage form of a drug substance.
Identification of drug
Solubility studies
Drug solubility studies were carried out in distilled water, ethanol, 
methyl alcohol, 1-propanol, acetone, 1-butanol, and in phosphate buffer 
pH 6.8.
Melting point determination
Melting point determination was carried out by capillary tube 
method [7].
Compatibility studies of the drug CBZ with the excipients
There should be an appreciable compatibility between the excipients 
and the drug for the formation of a stable formulation [8,9].
Fourier transform infrared spectroscopy (FTIR) studies
The FT-IR spectra of the samples were obtained to ascertain the 
compatibility between CBZ and the selected polymers by FT-IR 
method [10].
Formulation of CBZ microsphere (Table 1)
To the melted RBW taken in a china dish, dispersed the drug CBZ 
(40 mg) into it and the melted mixture was added to 100 ml distilled 
water at above 80°C. Surfactant of concentration 1.8% w/w of Tween 
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80 solution was poured into the mixture using a magnetic stirrer setted 
at 800 rpm for not more than 15-20 minutes which was then cooled to 
room temperature, filtered and then washing has to be done so as to get 
spherical shaped microspheres after air drying [11].
Characterization of microspheres
Drug content analysis
This was carried out using appropriate dilutions of drug with methanol 
at a wavelength of 285 nm spectrophotometrically using methanol as 
blank.
In vitro studies for drug release
Apparatus of Type II USP paddle was used for this study, and it 
was done by a standardized procedure, which was then analyzed 
spectrophotometrically at 285.5 nm [12].
Formulation of collagen rectal hydrogel containing CBZ RBW 
microspheres (Table 2)
Before the experiment the required quantity of collagen was cooled to 
a temperature below 10°C. 2.5% of collagen was taken in a beaker and 
added 0.5 ml of sodium hydroxide, 0.5 ml of pH 6.8 phosphate buffer and 
1 ml distilled water. These were mixed well. To this 1% of CBZ loaded 
RBW microspheres were added to obtain a gel of desired consistency. 
To this gel, two drops of glutaraldehyde were added and mixed.
Characterization of collagen rectal hydrogel
Physicochemical properties
Physicochemical evaluations such as pH measurement, homogeneity 
measurement, measurement of strength and consistency of hydrogels, 
spreadability, drug content, rheological studies, etc., were determined.
Surface pH measurement
The pH values of the hydrogels were determined by dispersing 1 g of 
each formulated hydrogel in 30 ml distilled water and recorded by a 
digital pH meter.
Homogeneity measurement
The hydrogels were visually inspected for general appearance and 
presence of any aggregates after they had been set in their final 
containers.
Measurement of strength and consistency of hydrogels
The gel strength was determined according to a method reported. 
A sample of 50 g of prepared hydrogel was placed in a 100 ml graduated 
cylinder. A standard weight of 35 g was placed onto the hydrogel 
surface. The strength of gel was determined by measuring the time 
in seconds taken by the weight to penetrate 5 cm down through the 
gel. Arrange of 10-50 seconds was acceptable for rectal application. 
A timeless than 10 seconds was considered to cause gel leakage out 
from the rectum whereas more than 50 seconds would be too viscous 
for rectal administration [13].
Spreadability
Spreadability parameter of the freshly prepared hydrogels was 
evaluated by an accepted procedure of sliding it between two glass 
slides.
Rheological studies
The Brookfield apparatus for viscosity measurement was done using 
a standardized procedure. Rotations of the gel were carried out for 
2 minutes in a spindle 7 and accordingly dial reading is recorded. 
A typical run should be carried out changing the speed from 10 to 
100 rpm at room temperature. For pseudoplastic flow, n>1 while for 
dilatancy, n<1.
In vitro mucoadhesion studies
The mucoadhesive properties of hydrogels loaded with CBZ 
microspheres were carried out. The method was based on assessing 
the time required for detachment of the hydrogel spread on the bovine 
rectal mucosa. Sections of the bovine rectum tissues were surgically 
removed and placed in saline solution. The tissues were stored frozen 
in phosphate buffer pH 6.8 and thawed to room temperature before 
use. At the time of testing, a section of bovine rectum tissue was tied 
on a beaker. A known quantity of hydrogel (1 g) was placed onto the 
rectal mucosa. The beaker was filled with 100 ml phosphate buffer 
pH 6.8 at 37±0.5°C and magnetically stirred at 100 rpm. The time for 
complete erosion of the hydrogels from the rectal mucosal surface 
was determined visually and recorded as an indication of the in vitro 
adhesion time [14].
In vitro drug release studies
A modified method was adopted, where a known quantity of the 
hydrogel was introduced into the glass tube of 2.5 cm diameter and 
3 cm length opened from both ends. The lower end of the tube was 
tightly covered with a dialysis membrane and the upper was hanged 
to the shaft of a USP Type II paddle apparatus dissolution rate rotating 
at rpm 100. The tubes were adjusted so that the dialysis membrane 
(Sigma-Aldrich) was below the surface of 100 ml pH 6.8 phosphate 
buffer maintained in 37±0.5°C condition at pH in between 6.5-7.2 range, 
imitating rectal fluid which is the desired medium for drug absorption. 
Aliquot samples were suitably diluted with phosphate buffer pH 6.8 and 
Table 1: Formulation composition of CBZ rice bran wax microspheres
S. No. Ingredients M1 M2 M3 M4 M5 M6 M7 M8 M9
1 RBW (g) 4 8 12 4 8 12 4 8 12
2 CBZ (mg) 30 30 30 40 40 40 50 50 50
3 CBZ: RBW(%w/w) 133 266 400 100 200 300 80 160 240
4 Tween 80 (%) 1.8 1.8 1.8 1.8 1.8 1.8 1.8 1.8 1.8
5 Distilled water (ml) 150 150 150 150 150 150 150 150 150
RBW: Rice bran wax, CBZ: Carbamazepine
Table 2: Formulation composition of collagen rectal hydrogel containing CBZ loaded RBW microspheres
S. No. Ingredients H1 H2 H3 H4 H5 H6
1 CBZ loaded RBW microspheres -M5 
optimized formulation (%)
1 1 1 1 1 1
2 Collagen (%) 10 15 20 25 30 35
3 Phosphate buffer pH 6.8 (ml) 0.5 0.5 0.5 0.5 0.5 0.5
4 Glutaraldehyde (drops) 2 2 2 2 2 2
5 Sodium hydroxide 0.1 N (ml) 0.5 0.5 0.5 0.5 0.5 0.5
6 Distilled water (ml) 10 10 10 10 10 10
CBZ: Carbamazepine, RBW: Rice bran wax
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analyzes spectrophotometrically in 285.5 nm. All experiments were 
carried out in triplicates and the mean values were presented [15].
Ex vivo permeation studies
This study was carried out in a specialized apparatus called the Franz 
diffusion cell having capacity of approximately 15 ml for receptor 
compartment by accepted procedure. A comparison study was done 
between optimized H4 hydrogel formulation, CBZ API loaded hydrogel 
(without microsphere) formulation, drug in phosphate buffer pH6.8 
solution, etc. [16,17].
Scanning electron microscopy (SEM)
The optimized hydrogel formulation (H5) were diluted with distilled 
water and examined with the SEM.
Histopathological examination
The pretreated mucosa which was subjected to the in vitro permeation 
was examined for any changes after accepted procedure [18].
Stability studies
The H4 rectal hydrogel was undergone stability evaluation for 60 days 
in refrigerated (4±2°C) and room temperature (30±2°C) condition and 
analyze for drug content [19-21].
RESULTS AND DISCUSSIONS
Solubility studies
The pure drug is partially soluble in water and ethanol and completely 
soluble in methanol, phosphate buffer pH 6.8.
Melting point of the drug
The result of M.P determination was in the range of 189°C-193°C.
FTIR studies
FTIR spectrum of CBZ, drug+RBW, plain RBW microspheres, collagen, 
physical mixture of drug with collagen and CBZ−RBW microspheres 
loaded collagen hydrogel formulations were shown in Fig. 1.
• FTIR spectra of CBZ showed characteristic absorption bands at 
3467/cm(NH stretching of NH2), 3080/cmaromaticity (aromatic 
CH stretching), 1678/cm(C=O stretching of CO NH2), 1605, 
1489/cm(C=C ring stretching) showed strong peak at 3029/
cmindicating the presence of –OH group.
• FTIR spectra of collagen showed strong peak at 1650/cm indicating 
the presence of amide I carbonyl stretching region, amide II at 
∼1560/cm, and a set of three weaker bands that represent amide 
III vibration modes centered at ∼1245/cm.
• FTIR peaks for RBW are at 2917-2852/cm, minor peaks at 1730, 
1497, 1461, and 1377/cm.
• The drug loaded hydrogel formulation exhibit a spectrum from 
3500 to 3300/cm indicating the presence of amine group. 3083/cm 
(aromatic CH stretching), 1678/cm (C=O stretching of CO NH2), 
showed strong peak at 3029.73/cm indicating the presence of –OH 
group.
• Absence of extra peaks indicates good compatibility between drug 
and the excipients.
Formulation of CBZ loaded RBW microspheres by modified cooling 
induced solidification method
The preparation strongly urges the need of optimization of certain 
parameters such as concentration of wax, speed rate of stirring, 
concentration of surfactant, and temperature. Optimum pH for 
maximum drug loading was found to be 6.8 with distilled water as the 
external phase. Tween 80 concentration was optimized to 1.8% w/w.
Drug content analysis
The drug content analysis was carried out for all prepared microsphere 
formulations. The drug content of all formulation ranged between 
57.23±0.14% to 92.33±0.36% as mentioned in Table 3 and Fig. 2. The 
maximum drug content was found to be 92.33±0.36% for microsphere 
formulation M5. Drug content in the formulation depends on the 
concentration of polymer in microsphere. Drug content increases with 
increase in polymer concentration. However, the pharmaceutically 
applicable drug loading was found to be maximum when the drug to 
polymer ratio was taken as 1:200% w/w.
IN VITRO RELEASE STUDIES OF DRUG
The release studies of drug loaded microsphere formulations were 
carried out for 12 hr (Fig. 3). 6.8 phosphate buffer was selected 
as the simulated rectal fluid which is the desired medium for drug 
absorption. The pH was maintained constant for the entire study 
duration using USP Type II Paddle dissolution apparatus. Maximum 
release was obtained for M5 and M8 formulations which are 
97.48±1.98% and 84.78±0.23%, respectively. The release of the drug 
from the formulation depends on the concentration of polymer, but if 
the concentration of the polymer is excessively increased release of 
Fig. 1: (a) Fourier transform infrared spectroscopy (FTIR) of carbamazepine (CBZ), (b) FTIR spectrum of CBZ+rice bran wax, (c) FTIR 
spectrum of plain rice bran wax microspheres, (d) FTIR spectrum of collagen, (e) FTIR spectrum of drug+collagen, and (f) FTIR spectrum 





Asian J Pharm Clin Res, Vol 10, Issue 3, 2017, 264-270
 Krishnapriya et al. 
• Biodegradability
• Viscosity enhancement property.
For the formulation of the hydrogel, collagen must be cooled to a 
temperature before the experiment. This is mandatory to obtain gel 
of desired consistency. The formulation was performed by varying the 
percentage of collagen between 10-35% w/w. According to the change 
in collagen concentration, a total of six formulations from H1 to H6 were 
prepared. The polymer must be added slowly to distilled water with 
constant stirring so that the formation of lumps could be avoided. The 
optimum amount of distilled water used was 10 ml. If the amount of 
distilled water was increased, the desired gel consistency could not be 
achieved. Sodium hydroxide (0.1 N) was added to adjust the pH. 1% of 
the optimized microsphere M5 formulation is incorporated to hydrogel 
after wetting it with 0.5 ml of phosphate buffer of pH 6.8. This wetting 
step was performed to enhance the distribution of microspheres. After 
the wetting process, the microspheres were uniformly distributed into 
the structured vehicle of hydrogels by gentle mixing with a mechanical 
stirrer. Glutaraldehyde is added as the cross linking agent to sustain 
the drug release and was again mixed until gel was formed, so the final 
concentration of CBZ in hydrogels was 1% w/w, shown in Fig. 4.
Characterization of collagen rectal hydrogel
Surface pH measurement
The formulated hydrogels had pH values in range of 6.5-7.4, which 
were close to the rectal pH of 6.8. Hence, these values indicated the 
suitability of the hydrogels for rectal application with minimal risk of 
tissue irritation.
Homogeneity measurement
All the formulated hydrogels showed good homogeneity with the 
absence of lumps, indicates uniform distribution of drug within the 
formulation.
Measurement of strength and consistency of hydrogels
The strengths of collagen hydrogels H1-H4 were within the acceptable 
range (10-50 s). The H5 and H6 formulations showed a higher strength 
reaching 59.32 and 63.4 seconds, respectively. These values clearly 
revealed that the strength of collagen hydrogels could not be considered 
suitable for rectal application (Fig. 5).
Spreadability
The formulated hydrogels exhibited satisfactory spreadability 
which points to equality to application of drug. The spreadability 
of the optimized hydrogel formulation H4 was in the range of 
25.48±2.78 g cm/seconds.
Drug content analysis
For any formulation there should be uniformity in drug distribution, 
hence the desired therapeutic concentration will be reached to the 
specific site. This will give a clear indication of its action in the body. 
All the formulations exhibited fairly appreciable drug content. Simple 
and less complicated procedure will account minimum chance of 
drug, i.e., addition of 1% of optimized formulation of drug bearing 
microsphere (M5) to the polymer solution. The drug content was 
observed in the range of 88.73±0.45% to 97.48±0.62% (Fig. 6). 
The optimized formulation H4 containing 25% of collagen showed 
maximum drug content.
Rheological studies
H1-H4 formulations were suitable for rheological studies after taking 
viscosity measurements shown in Fig. 7.
In vitro mucoadhesion studies
Fig. 8 presented the bioadhesion time taken by hydrogel formulae to 
erode from the rectal mucosal tissue. It was observed that H4 hydrogel 
the drug gets affected. The optimized formulation was found to be M5 
which exhibits highest percentage of release in a controlled manner 
for 12 hr. This controlled release with high percentage of release was 
due to optimized drug to wax ratio. M5 formulation contains 1% w/w 
of drug and drug to polymer ratio of 1:200. Further, optimized 
formulation M5 was selected for the formulation of collagen rectal 
hydrogel [22].
Formulation of collagen rectal hydrogel containing CBZ RBW 
microspheres
Preparation of collagen hydrogel
Hydrogels were prepared using 1% w/w of optimized M5 microspheres. 
Here, the polymer used was collagen which is a natural one. It is an 
abundant structural protein in all animals. Collagen is selected as the 




Table 3: Determination of percentage drug content










Fig. 2: Determination of percentage drug content
Fig. 3: In vitro release of carbamazepine loaded rice bran wax 
microspheres
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formulation had the highest in vitro adhesion time (565 minutes), 
whereas the adhesion time of other hydrogels was comparatively lesser. 
Collagen is a good mucoadhesive agent. The polymer concentration 
and bioadhesion time had a linear proportionality relationship. 
Furthermore, the mucoadhesion time will be greater up to collagen 
concentration of 25% and further increase in collagen concentration 
showed decreased bioadhesion. The high residence time shown by the 
prepared rectal hydrogels gave a chance to the loaded microspheres to 
be attached to the mucosal surface and slowly elute the drug providing 
a controlled effect.
In vitro drug release studies
The study was conducted for duration of 12 hrs and release percentage 
from 0 to 12 hrs was taken. From H1-H4, the percentage value of release 
of drug value was considerably increased and dropped subsequently 
for H5 and H6 formulation. Maximum release was obtained for H4 
formulation with 96.45±0.35% than other formulations shown in Fig. 9. 
Equal amount of drug loaded microspheres were used to formulate 
all six hydrogel formulations, but the % of polymer (collagen) used 
varies. These hydrogels act as a reservoir which release the drug at 
a minimum pace, in a sustained manner at a considerable duration. 
50H4 formulation contains 25% collagen which could be concluded as 
the optimum collagen concentration to exhibit maximum percentage 
release. Further increment in polymer % showed a fall in percentage 
release (H5 and H6 formulations).Kinetic studies were also performed.
Ex vivo permeation studies
The rectal mucosa represents a layer with high vascularization. 
The bovine rectal mucosa was selected because of its physiological 
resemblance to human rectal mucosa and the studies were conducted 
in Franz diffusion cell. The ex vivo permeation study gives a clear idea 
about the behavior of the moiety in vivo. There is proportionality 
Fig. 5: Gel strength
Fig. 6: Drug content of different hydrogel formulations
Fig. 8: Comparison of mucoadhesion time of different 
formulations
Fig. 9: In vitro drug release of different formulations of 
carbamazepine rice bran wax microsphere loaded hydrogel 
formulations
Fig. 7: Rheological properties of selected hydrogel formulationsFig. 4: (a) Carbamazepine rice bran wax microsphere loaded 
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between the quantity of drug permeated and the quantity of drug 
absorbed. A comparison study was done between optimized H4 hydrogel 
formulation, CBZ API hydrogel (without microsphere) formulation, 
drug in phosphate buffer pH 6.8 solution, etc. The ex vivo permeation 
studies were performed only for 12 hrs as the rectal mucosa undergoes 
degradation when it was kept for longer period which was indicated by 
foul smell. The ex vivo permeation studies as seen in Fig. 10 confirmed 
that the optimized formulation H4 shows maximum permeation.
Histopathological examination
As shown in Fig. 11, histopathological study of the rectal mucosa 
after permeation study suggested that the optimized hydrogel H4 
formulation was safe for rectal administration.
SEM
The discrete and spherical shaped with a rough outer surface and 
visible wrinkles are shown in SEM studies (Fig. 12).
Stability studies
From the stability studies (Fig. 13) the optimized H4 hydrogel 
formulation, it was confirmed that H4 formulation was stable at two 
different conditions.
CONCLUSION
A number of delivery systems have been investigated for use in 
neurological disorders like epilepsy, but still a novel delivery system 
to combat this incurable firing disorder is yet to be developed. 
Antiepileptic medications are used as first line treatment option but 
conventional therapy is accompanied by a handful of side effects. 
Rectal route offers a noninvasive useful route of drug administration 
when systemic or local effects are requested. Rectal administration is 
of now widely employed which could be as effective as the intravenous 
route. Furthermore nonmedical personnel, irrespective of the patient’s 
ability to cooperate can administer rectal formulations easily and 
safely. Hydrogels are highly nonirritant and tissue compatible due 
to its excessive moisture content and resemblance to the natural cell 
environment. Collagen hydrogels containing CBZ RBW microspheres 
have been prepared and evaluated. The formula of 25% collagen loaded 
with CBZ RBW microspheres (H4 formulation) showed adequate 
rheological, mucoadhesive, and permeability properties. The suggested 
formula allowed the adhesion of hydrogel loaded with the drug CBZ to 
the rectal mucosa for subsequent sustained release behavior with no 
burst effect, which is a major disadvantage of CBZ immediate release 
systems. In vitro release kinetics of formulation clearly indicated that 
the CBZ microsphere loaded hydrogels exhibited zero order release 
following Higuchi model as the diffusion mechanism. Histopathological 
examination demonstrated that the optimized H4 hydrogel formulation 
produce neither mucosal remodeling nor rectal irritancy and hence 
evaluated to be safe for rectal administration. The main purpose of this 
work which was to formulate a rectal hydrogel with sustained release 
of drug so as to minimize drug related adverse effects and frequency of 
dosage was successfully attained.
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